Samsung NEXT Ventures

Samsung NEXT Ventures, established in 2013, is a venture capital arm of Samsung Electronics, headquartered in Mountain View, California. It focuses on investing in early-stage companies within the artificial intelligence, fintech, blockchain, health technology, infrastructure, and media technology sectors. The firm typically invests a minimum of USD 1 million, supporting innovative startups that align with Samsung's strategic growth opportunities.

Royi Benyossef

Investment Director

Sam Campbell

Investor

Carlos Castellanos

Investor

Andy Duong

Investment Director

Lizzy Goldman

Investor

Joan Kim

Investor

Emily Koster

Director of Communications

Amy Lee

Investor

Raymond Liao

Vice President | Ventures Managing Director

Jonathan Machado

Managing Director, Investment

Yonatan Machado

Senior Investment Director

Eyal Miller

Managing Director, General Manager, Israel

Nick Nigam

Principal, Seed to Series B Venture Capital Investments

Caroline Rehfuss

Investor

Past deals in Wearables

Afference

Seed Round in 2024
Afference is an electronics manufacturing company specializing in wearable technology that bridges the gap between the digital and physical worlds. The company has developed a haptic glove that utilizes neural stimulation to simulate the sensation of touch, allowing users to engage with 3D digital content and immersive environments. This innovative device is designed for various applications, including extended reality, gaming, and entertainment, enabling users to interact freely and realistically within digital spaces. Through its advanced technology, Afference aims to enhance the user experience by providing a tactile connection that enriches digital interactions.

Forward

Series E in 2023
Forward is a startup focused on transforming healthcare delivery by incorporating advanced technologies that have been underutilized in the industry, such as sensors, mobile applications, and artificial intelligence. Founded in January 2016 by former executives from Google and Uber, Forward operates primary care clinics that emphasize personalized patient care. Through its mobile application and natural language processing system, the company enhances healthcare services, offering features like body scanning, genetic screening, real-time blood testing, and home monitoring of vital signs. These innovations empower patients to take control of their health, promote transparency, and foster better collaboration with their primary care physicians. Backed by prominent investors and entrepreneurs, Forward aims to redefine the patient experience in healthcare.

Signos

Series B in 2023
Signos is a health technology company focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through innovative solutions. The company offers a weight loss application that leverages continuous glucose monitoring in conjunction with an AI-enhanced platform. This combination provides users with real-time data and personalized recommendations for meals and exercises tailored to their unique metabolic responses. By enabling individuals to better understand their body's reactions to food, Signos aims to facilitate effective weight loss and foster sustainable health improvements. With a significant portion of the American population facing weight-related challenges, Signos presents a modern approach to support users on their journey towards healthier living.

Ixana

Seed Round in 2022
Ixana is a wearable hardware company that focuses on developing advanced human-computer interfaces. The company specializes in creating wire-free, augmented reality devices that feature an all-day battery life. By utilizing real-time artificial intelligence and a specialized silicon chipset, Ixana aims to address critical challenges related to power consumption, data rates, latency, and signal reliability. This innovative approach positions Ixana as a key player in the evolving landscape of wearable technology, enhancing user interaction with digital environments.

Genopets

Seed Round in 2022
Genopets is a mobile game that combines the concepts of fitness and gaming through a Free-to-Play, Move-to-Earn model. Players nurture digital pets, known as Genopets, whose growth and evolution are directly linked to the user's physical activity. The game tracks steps taken through mobile devices and fitness wearables, translating these into rewards within the game environment. By engaging in daily physical activities such as walking or jogging, players can earn cryptocurrency while forging an emotional bond with their Genopet. This unique approach gamifies an active lifestyle, encouraging users to maintain their fitness in a fun and rewarding way, reminiscent of the nostalgic experiences of caring for virtual pets or Pokémon. Ultimately, Genopets aims to motivate individuals to lead healthier lives through an interactive and engaging platform.

Aviron

Seed Round in 2021
Aviron Interactive is a fitness company that specializes in providing innovative workout equipment designed for home use. Their flagship product, a connected rowing machine, incorporates gamification features to enhance the user experience. The rowing machine offers short, high-intensity workouts and adjustable resistance settings that combine cardiovascular and strength training. Aviron's platform includes a wide variety of engaging content, including workout programs curated by experienced trainers, as well as interactive games and competitions, ensuring users remain motivated and engaged over time. Through these offerings, Aviron aims to transform traditional workout routines into dynamic and enjoyable fitness experiences.

Terra API

Seed Round in 2021
Terra API is a developer of an online application programming interface that facilitates the transfer of health data across various platforms. The company's API allows applications to connect seamlessly with health apps, wearables, sensors, and blood laboratories. By accepting form-encoded request bodies and returning responses in JavaScript Object Notation, Terra API provides a streamlined method for application developers to enable users to share and access fitness data from multiple devices. This functionality enhances the integration of health-related technologies, promoting easier data exchange in the health and wellness sector.

Huma

Series C in 2021
Huma is a global health technology company that specializes in creating a modular platform for digital 'hospitals at home' across various disease areas. The platform integrates predictive algorithms, digital biomarkers, and real-world data to enhance proactive and predictive healthcare. By connecting information from hospital databases, patient wearables, and mobile devices, Huma provides healthcare providers with real-time insights. The company focuses on advancing connected care for patients and accelerating research and therapy development. It collaborates with leading healthcare institutions to assess and improve health outcomes, empowering healthcare professionals to utilize data effectively for better patient care.

HealthifyMe

Series B in 2018
HealthifyMe is a fitness application that supports users in achieving their health and weight loss objectives through digital platforms, including computers and smartphones. Launched in 2012 and based in Bangalore, India, the application allows users to track calories, nutrition, and fitness activities while monitoring their weight and overall health. It also enables users to set personalized health goals and access expert advice from nutritionists and fitness trainers. The platform features an artificial intelligence-powered fitness coach that uses automated analytics to help users manage their dietary intake and receive tailored online fitness consultations. Through its comprehensive tools and expert guidance, HealthifyMe aims to enhance individual wellness and promote healthier lifestyles.

HealthifyMe

Series B in 2018
HealthifyMe is a fitness application that supports users in achieving their health and weight loss objectives through digital platforms, including computers and smartphones. Launched in 2012 and based in Bangalore, India, the application allows users to track calories, nutrition, and fitness activities while monitoring their weight and overall health. It also enables users to set personalized health goals and access expert advice from nutritionists and fitness trainers. The platform features an artificial intelligence-powered fitness coach that uses automated analytics to help users manage their dietary intake and receive tailored online fitness consultations. Through its comprehensive tools and expert guidance, HealthifyMe aims to enhance individual wellness and promote healthier lifestyles.

Glooko

Series C in 2017
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Glooko

Series C in 2016
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Glooko

Series B in 2015
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

BioBeats

Seed Round in 2015
BioBeats, established in 2012 and headquartered in London, specializes in digital health solutions for personal wellness. The company leverages artificial intelligence and real-time data from smartphones and wearables to tackle global mental health challenges. By fusing research from the University of Oxford, BioBeats creates AI products that track neurological and physiological correlates to psychological progress, predict disorder onset, and provide personalized support. Their psychological wellness application calculates a baseline wellbeing score and offers insights into stress responses, enabling users to identify harmful patterns and improve their overall mental health.

Glooko

Series A in 2014
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.